講演情報

[WS08-17-P]Multi-omics Analysis of Autoantibody-Mediated Suppression of Type I Interferon Signaling in Myeloid Cells in Severe COVID-19 Patients

^○Masahiro Kiuchi¹, Chiaki Iwamura^1,2, Kaori Tsuji¹, Atsushi Sasaki¹, Takahisa Hishiya¹, Rui Hirasawa¹, Kota Kokubo¹, Atushi Onodera¹, Motoko Kimura^2,3, Shinichiro Motohashi⁴, Kiyoshi Hirahara^1,2,5 (1.Department of Immunology, Graduate School of Medicine, Chiba University, 2.Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, 3.Department of Experimental Immunology, Graduate School of Medicine, Chiba University, 4.Department of Medical Immunology, Graduate School of Medicine, Chiba University, 5.AMED-CREST)

キーワード：

COVID-19、Type I interferons、BCR repertoire、IFN-α2

閲覧にはパスワードが必要です

ログイン

または

セッション詳細へ戻る